Overexpression of Prdx6 and resistance to peroxide-induced death in Hepa1-6 cells: Prdx suppression increases apoptosis

Redox Report

Volumn 14, Issue 6, 2009, Pages 275-284

  Walsh, Bridget ^a   Pearl, Amanda ^a   Suchy, Sarah ^a   Tartaglio, John ^a   Visco, Kristin ^a   Phelan, Shelley A ^a  

^a FAIRFIELD UNIVERSITY   (United States)

Author keywords

Apoptosis; Hepa1 6 cell; Peroxiredoxins; Prdx6

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; MESSENGER RNA; MITHRAMYCIN A; PEROXIDE; PEROXIREDOXIN 6; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL SPECIFICITY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEPATOMA CELL; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; APOPTOSIS; CELL LINE; HUMANS; LIVER NEOPLASMS; MICE; PEROXIDES; PEROXIREDOXIN VI; PEROXIREDOXINS; PLICAMYCIN; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 73949104703     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/135100009X12525712409652     Document Type: Article

References (42)

1. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine, 3rd edn. New York: Oxford University Press, 1999.
2. Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005; 7: 768-777.
3. Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 2002; 383: 347-364.
4. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005; 38: 1543-1552.
5. Cross C, Halliwell B, Borish E et al. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-545.
6. Sun A, Chen Y. Oxidative stress and neurodegenerative disorders. J Biomed Sci 1998; 5: 401-414.
7. Gius D, Spitz D. Redox signaling in cancer biology. Antioxid Redox Signal 2006; 8: 1249-1252.
8. Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 2001; 21: 2085-2090.
9. Kinnula VL, Lehtonen S, Sormunen R et al. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 2002; 196: 316-323.
10. Karihtala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res 2003; 15: 3418-3424.
11. Lehtonen ST, Svensk AM, Soini Y et al. Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 2004; 111: 514-521.
12. Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Enhanced expression of peroxiredoxin I. and V. I. Correlates with development recurrence and progression of human bladder cancer. J Urol 2006; 175: 1512-1516. (Pubitemid 43313061)
13. Chang XZ, Li DQ, Hou YF et al. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007; 9: R76.
14. Butterfield LH, Merino A, Golub SH, Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal 1999; 1: 385-402.
15. Kinnula VL, Paakko P, Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004; 569: 1-6.
16. Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 2007; 7: 375-380.
17. Manevich Y, Fisher AB. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 2005; 38: 1422-1432.
18. Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V, Fisher AB. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci USA 2002; 99: 11599-11604.
19. 2 but does not prevent diet-induced atherosclerosis. Free Radic Biol Med 2003; 35: 1110-1120.
20. Wang Y, Manevich Y, Feinstein SI, Fisher AB. Adenovirus-mediated transfer of the 1-Cys peroxiredoxin gene to mouse lung protects against hyperoxic injury. Am J Physiol 2004; 286: L1188-L1193.
21. Wang Y, Phelan SA, Manevich Y, Feinstein SI, Fisher AB. Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am J Respir Cell Mol Biol 2006; 34: 481-486.
22. 2-induced oxidative stress. J Cell Biochem 2008; 104: 1274-1285.
23. Pak JH, Manevich Y, Kim HS, Feinstein SI, Fisher AB. An antisense oligonucleotide to 1-Cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells. J Biol Chem 2002; 277: 49927-49934.
24. Wang X, Phelan SA, Forsman-Semb K et al. Mice with targeted mutation of peroxiredoxin 6 develop normally but are susceptible to oxidative stress. J Biol Chem 2003; 278: 25179-25190.
25. Kumin A, Huber C, Rulicke T, Wolf E, Werner S. Peroxiredoxin 6 is a potent cytoprotective enzyme in the epidermis. Epithel Mesenchym Cell Biol 2006; 169: 1194-1205.
26. Wang Y, Feinstein SI, Manevich Y, Ho YS, Fisher AB. Peroxiredoxin 6 gene-targeted mice show increased lung injury with paraquat induced oxidative stress. Antioxid Redox Signal 2006; 8: 229-237.
27. Sparling N, Phelan SA. Identification of multiple transcripts for antioxidant protein 2 (AOP2): differential regulation by oxidative stress and growth factors. Redox Reports 2003; 8: 87-94.
28. Gallagher BM, Phelan SA. Transcriptional regulation of peroxiredoxin 6 in mouse liver cells. Free Radic Biol Med 2007; 42: 1270-1277.
29. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2Δ ΔCT method. Methods Enzymol 2001; 25: 402-408.
30. Gardiner F, Gaynor P, Phelan SA. Induction of Prdx1 and Prdx6 in liver cells by serum and TPA. Int J Biol 2010; 2: In press.
31. Gu S, Villegas C, Jiang J. Differential regulation of amino acid transporter SNAT3 by insulin in hepatocytes. J Biol Chem 2005; 280: 26055-26062.
32. Hasty A, Shimano H, Yahagi N et al. Sterol regulatory elementbinding protein-1 is regulated by glucose at the transcriptional level. J Biol Chem 2000; 275: 31068-31077.
33. Lora J, Rowader K, Soares L, Giancotti F, Zaret K. Alpha3beta1- integrin as a critical mediator of the hepatic differentiation response to the extracellular matrix. Hepatology 1998; 28: 1095-1104.
34. Sass G, Leukel P, Schmitz V et al. Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer 2008; 123: 1269-1277.
35. Herold C, Ganslmayer M, Ocker M, Hermann M, Hahn E, Schuppan D. Combined in vitro anti-tumoral action of tamoxifen and retinoic acid derivatives in hepatoma cells. Int J Oncol 2002; 20: 89-96.
36. Conde de la Rosa L, Schoemaker M, Vrenken T et al. Superoxide anions and hydrogen peroxide induce hepatocyte death by different mechanisms: involvement of JNK and ERK MAP kinases. J Hepatol 2006; 44: 918-929.
37. Saberi B, Shinohara M, Ybanez M et al. Regulation of H(2)O(2)- induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes. Am J Physiol 2008; 295: C50-C63.
38. Fujita Y, Nakanishi T, Hiramatsu M et al. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Clin Cancer Res 2006; 12: 6415-6420.
39. Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer 2005; 41: 2438-2448.
40. Neumann CA, Krause DS, Carman CV. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defense and tumour suppression. Nature 2003; 424: 561-565.
41. Cao J, Schulte J, Knight A et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity. EMBO J 2009; 28: 1505-1517.
42. Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C. Loss-offunction of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 2005; 65: 6773-6779.